Literature DB >> 20109358

Clinical assessment of the efficacy of anti-cancer treatment: current status and perspectives.

Jing-Jing Zhang1, Qiong Meng, Wei Chang, Chong-Hua Wan.   

Abstract

With continued enhancements in cancer diagnosis and treatment, clinical assessments are deeper. More composite indicators are applied and evaluations are more "patient-centered", focusing on disease status and response to treatment, as well as the quality-of-life of patients as primary components, including the patients themselves, clinical staff, caregivers, and medical examinations, and other aspects of the evaluation. We reviewed the current research on the application and development of clinical assessment indicators for traditional Chinese medicine (TCM) and modern medicine, and explored its significance and the advancements in effective evaluations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20109358     DOI: 10.5732/cjc.009.10598

Source DB:  PubMed          Journal:  Chin J Cancer        ISSN: 1944-446X


  4 in total

Review 1.  Establishing Chinese medicine characteristic tumor response evaluation system is the key to promote internationalization of Chinese medicine oncology.

Authors:  Jie Li; Lei Li; Rui Liu; Hong-sheng Lin
Journal:  Chin J Integr Med       Date:  2012-09-11       Impact factor: 1.978

2.  Comparative effectiveness of Di'ao Xin Xue Kang capsule and Compound Danshen tablet in patients with symptomatic chronic stable angina.

Authors:  Yanan Yu; Siyuan Hu; Guoxin Li; Jie Xue; Zhuoming Li; Xiangling Liu; Xiyan Yang; Bo Dong; Donghai Wang; Xiaofeng Wang; Shurong Liu; Jun Liu; Bingwei Chen; Liying Wang; Songshan Liu; Qiguang Chen; Chunti Shen; Zhong Wang; Yongyan Wang
Journal:  Sci Rep       Date:  2014-11-14       Impact factor: 4.379

3.  Guizhi Fuling Wan, a Traditional Chinese Herbal Formula, Sensitizes Cisplatin-Resistant Human Ovarian Cancer Cells through Inactivation of the PI3K/AKT/mTOR Pathway.

Authors:  Li Han; Xiaojuan Guo; Hua Bian; Lei Yang; Zhong Chen; Wenhua Zang; Jingke Yang
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-18       Impact factor: 2.629

4.  Chinese patent medicine (Jinlong Capsule) for gastric cancer: Protocol for a systematic review and meta-analysis.

Authors:  Jianwei Li; Bin Han; Guangzong Sun; Zhong Zheng; Ying Mu; Jingxia Chi
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.